Louisbourg Investments Inc. Cuts Position in Agilent Technologies, Inc. $A

Louisbourg Investments Inc. cut its holdings in Agilent Technologies, Inc. (NYSE:A) by 22.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 36,056 shares of the medical research company’s stock after selling 10,313 shares during the period. Louisbourg Investments Inc.’s holdings in Agilent Technologies were worth $4,789,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in Agilent Technologies by 4.3% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock valued at $82,712,000 after buying an additional 24,687 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its holdings in Agilent Technologies by 20.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company’s stock worth $7,269,000 after buying an additional 9,236 shares during the last quarter. Crossmark Global Holdings Inc. raised its position in Agilent Technologies by 39.6% in the fourth quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company’s stock worth $4,615,000 after acquiring an additional 9,615 shares during the period. Capricorn Fund Managers Ltd bought a new stake in Agilent Technologies in the first quarter worth about $8,161,000. Finally, Dudley & Shanley Inc. boosted its stake in Agilent Technologies by 25.9% in the second quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock valued at $9,232,000 after acquiring an additional 14,300 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on A. Robert W. Baird increased their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Weiss Ratings upgraded Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Morgan Stanley increased their price objective on Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a report on Wednesday. Finally, HSBC decreased their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Stock Performance

NYSE A opened at $149.33 on Friday. The firm has a market cap of $42.18 billion, a P/E ratio of 29.99, a price-to-earnings-growth ratio of 2.62 and a beta of 1.25. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The company’s 50 day moving average is $135.12 and its 200-day moving average is $125.40. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same period last year, the firm earned $1.31 EPS. Agilent Technologies’s revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were issued a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.